Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Star
6396.0000
-89.50
(
-1.38
%)
NSE
Jan 13, 2026
13:13 PM
29.08% Gain from 52W Low
Volume:
161.7K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
23 May 2022
6396.00
-1.38%
Ends FY22 on a strong note
Buy:
Divi's Laboratories Ltd.
by
Motilal Oswal
Target: 4480
Target
Motilal Oswal
Divi's Laboratories .. has an
average target
of 6432.50 from 6 brokers.
More from Divi's Laboratories Ltd.
Recommended
Market trades lower, KPI Green Energy signs Rs 4,000 crore renewable energy pact
Trendlyne Marketwatch |
13 Jan 2026, 01:04PM
IPO wave continues as Amagi Media and Five SMEs open for subscription
|
12 Jan 2026, 06:40PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022